Zika virus infection laboratory findings

Revision as of 15:38, 21 December 2015 by Nate Michalak (talk | contribs)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Zika virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Zika Virus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Evaluation of Pregnant Women

Evaluation of Infants

Collection and Submission of Fetal Tissues

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission

Secondary Prevention

CDC Response Planning Tips

Risk-based Preparedness for States

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zika virus infection laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zika virus infection laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zika virus infection laboratory findings

CDC on Zika virus infection laboratory findings

Zika virus infection laboratory findings in the news

Blogs on Zika virus infection laboratory findings

Directions to Hospitals Treating Zika virus infection

Risk calculators and risk factors for Zika virus infection laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.

Overview

Blood serum and plasma testing is conducted to detect viral nucleic acids or virus specific IgM. Laboratory testing is the primary source when differentiating between Zika and other commonly misdiagnosed viruses.[1]

Laboratory Findings

  • During the first week after onset of symptoms, Zika virus can often be diagnosed by performing reverse transcriptase-polymerase chain reaction (RT-PCR) on serum.
  • Virus-specific IgM and neutralizing antibodies typically develop toward the end of the first week of illness.
  • Cross-reaction with related flaviviruses (e.g., dengue and West Nile viruses) is common and may be difficult to discern.
  • Plaque-reduction neutralization testing can be performed to measure virus-specific neutralizing antibodies and discriminate between cross-reacting antibodies in primary flavivirus infections.[2]

References

  1. Zika virus. Center for Disease Control and Prevention for Medical Professionals. http://www.cdc.gov/zika/hc-providers/clinicalevaluation.html Accessed on December 10, 2015
  2. For HealthCare Providers: Diagnostic Testing. Center for Disease Control and Prevention. http://www.cdc.gov/zika/hc-providers/diagnostic.html Accessed December 21, 2015.